A. Ernest WhitonChief Financial OfficerZOLL Medical Corporation+1 (978) 421-9655
Diane EganZOLL Medical Corporation+1 (978) firstname.lastname@example.org
FOR IMMEDIATE RELEASE
Scheduled Lunch Symposium to Encourage Further Dialogue on CPR Quality and Performance
9 MAY, 2006—STAVANGER, NORWAY—ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of resuscitation devices and software solutions, will display products with features that can be used to implement new 2005 European Resuscitation Council (ERC) Guidelines recommendations. ZOLL’s E Series® meets the recommendations that include delivering CPR before the first shock, delivering single shocks, and programming the CPR time-period between shocks while in AED mode. Furthermore, ZOLL’s AED Pro® with Real CPR Help™, and AutoPulse® Non-invasive Cardiac Support Pump now support the new recommendation of early and more chest compressions during CPR.
ERC made these recommendations to provide longer periods of uninterrupted chest compressions and to simplify the CPR process for laypeople and healthcare professionals. ZOLL will display these products—and other advanced resuscitation offerings—in Stand #26 at the 8th Scientific Congress of the European Resuscitation Council from 11 May through 13 May at the Stavanger Forum.
Since 2002, with the launch of the ZOLL AED Plus™ with Real CPR Help technology, ZOLL has been working to incorporate instantaneous CPR support in its products. “ZOLL was the first manufacturer at the time to recognize the importance of helping rescuers with CPR performance,” said Richard A. Packer, President and Chief Executive Officer of ZOLL. “This approach has been validated by the strong emphasis on CPR in the 2005 ERC Guidelines. To date, ZOLL estimates that more than 500,000 rescuers worldwide have access to ZOLL AEDs that can help them performhigh-quality CPR. We will continue our commitment to offer such novel technologies that help lay rescuers and healthcare professionals provide high-quality CPR and improve their resuscitation efforts so that more people survive cardiac arrest.”
In keeping with ZOLL’s vision to help improve CPR quality and increase survival rates, ZOLL will hold a lunch symposium on 11 May about CPR performance and methods to implement new Guidelines recommendations. The leading resuscitation expert Hans-Richard Arntz, M.D., Professor at the renowned University-Klinikum Benjamin Franklin in Berlin, will moderate the proceedings.
Additional participants scheduled to appear include:
ZOLL will be showing the following Guidelines-Ready products:
ZOLL will also be displaying the following products:
ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.
ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East, Asia, and Australia. For more information, visit www.zoll.com or call +1 (978) 421-9655.
Certain statements contained in this press release, including statements regarding the anticipated development of ZOLL’s business, potential sales levels, its ability to differentiate its products from others on the market, and other statements contained herein regarding matters that are not historical facts, are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to the ability of the ZOLL sales force to market successfully multiple resuscitation products, and those factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on February 10, 2006.
© 2006 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. AED Plus, CPR-D•padz, EasyRead Tri-Mode Display, Real CPR Help, and Rectilinear Biphasic are trademarks of ZOLL Medical Corporation. AED Pro, AutoPulse, E Series, LifeBand, M Series, and ZOLL are registered trademarks of ZOLL Medical Corporation. ResQPOD is a registered trademark of Advanced Circulatory Systems, Inc. All trademarks are property of their respective owners.
* Clinical data available upon request.